vs
GULFPORT ENERGY CORP（GPOR）与ICU MEDICAL INC（ICUI）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是GULFPORT ENERGY CORP的1.4倍（$540.7M vs $398.2M），GULFPORT ENERGY CORP净利率更高（33.3% vs -2.9%，领先36.2%），GULFPORT ENERGY CORP同比增速更快（66.0% vs -14.1%），过去两年GULFPORT ENERGY CORP的营收复合增速更高（18.6% vs -2.3%）
Gulfport Energy Corp是一家总部位于美国的独立油气勘探生产企业，核心运营区域覆盖俄亥俄州尤蒂卡页岩区、俄克拉荷马州SCOOP产区，主要生产天然气、原油及天然气液，供应北美工业、公用事业及商业终端市场。
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
GPOR vs ICUI — 直观对比
营收规模更大
ICUI
是对方的1.4倍
$398.2M
营收增速更快
GPOR
高出80.1%
-14.1%
净利率更高
GPOR
高出36.2%
-2.9%
两年增速更快
GPOR
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $398.2M | $540.7M |
| 净利润 | $132.4M | $-15.7M |
| 毛利率 | 76.6% | 37.5% |
| 营业利润率 | 44.9% | 1.0% |
| 净利率 | 33.3% | -2.9% |
| 营收同比 | 66.0% | -14.1% |
| 净利润同比 | 148.5% | 34.0% |
| 每股收益（稀释后） | $7.98 | $-0.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GPORICUI
| Q4 25 | $398.2M | $540.7M | ||
| Q3 25 | $379.7M | $537.0M | ||
| Q2 25 | $447.6M | $548.9M | ||
| Q1 25 | $197.0M | $604.7M | ||
| Q4 24 | $239.9M | $629.8M | ||
| Q3 24 | $253.9M | $589.1M | ||
| Q2 24 | $181.1M | $596.5M | ||
| Q1 24 | $283.2M | $566.7M |
净利润GPORICUI
| Q4 25 | $132.4M | $-15.7M | ||
| Q3 25 | $111.4M | $-3.4M | ||
| Q2 25 | $184.5M | $35.3M | ||
| Q1 25 | $-464.0K | $-15.5M | ||
| Q4 24 | $-273.2M | $-23.8M | ||
| Q3 24 | $-14.0M | $-33.0M | ||
| Q2 24 | $-26.2M | $-21.4M | ||
| Q1 24 | $52.0M | $-39.5M |
毛利率GPORICUI
| Q4 25 | 76.6% | 37.5% | ||
| Q3 25 | 74.6% | 37.4% | ||
| Q2 25 | 80.7% | 37.9% | ||
| Q1 25 | 57.9% | 34.7% | ||
| Q4 24 | 63.2% | 36.1% | ||
| Q3 24 | 64.6% | 34.8% | ||
| Q2 24 | 52.2% | 34.8% | ||
| Q1 24 | 69.4% | 32.7% |
营业利润率GPORICUI
| Q4 25 | 44.9% | 1.0% | ||
| Q3 25 | 41.9% | 2.6% | ||
| Q2 25 | 56.0% | 1.9% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | -131.3% | 6.0% | ||
| Q3 24 | 5.7% | 1.4% | ||
| Q2 24 | -10.0% | 1.3% | ||
| Q1 24 | 28.9% | -1.9% |
净利率GPORICUI
| Q4 25 | 33.3% | -2.9% | ||
| Q3 25 | 29.3% | -0.6% | ||
| Q2 25 | 41.2% | 6.4% | ||
| Q1 25 | -0.2% | -2.6% | ||
| Q4 24 | -113.9% | -3.8% | ||
| Q3 24 | -5.5% | -5.6% | ||
| Q2 24 | -14.5% | -3.6% | ||
| Q1 24 | 18.4% | -7.0% |
每股收益（稀释后）GPORICUI
| Q4 25 | $7.98 | $-0.63 | ||
| Q3 25 | $4.45 | $-0.14 | ||
| Q2 25 | $9.12 | $1.43 | ||
| Q1 25 | $-0.07 | $-0.63 | ||
| Q4 24 | $-14.72 | $-0.97 | ||
| Q3 24 | $-0.83 | $-1.35 | ||
| Q2 24 | $-1.51 | $-0.88 | ||
| Q1 24 | $2.34 | $-1.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8M | — |
| 总债务越低越好 | $788.2M | — |
| 股东权益账面价值 | $1.8B | $2.1B |
| 总资产 | $3.0B | $4.1B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资GPORICUI
| Q4 25 | $1.8M | — | ||
| Q3 25 | $3.4M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $1.5M | $308.6M | ||
| Q3 24 | $3.2M | $312.5M | ||
| Q2 24 | $1.2M | $302.6M | ||
| Q1 24 | $8.2M | $251.4M |
总债务GPORICUI
| Q4 25 | $788.2M | — | ||
| Q3 25 | $691.7M | — | ||
| Q2 25 | $695.2M | — | ||
| Q1 25 | $700.4M | — | ||
| Q4 24 | $702.9M | — | ||
| Q3 24 | $694.4M | — | ||
| Q2 24 | $679.5M | — | ||
| Q1 24 | $636.4M | — |
股东权益GPORICUI
| Q4 25 | $1.8B | $2.1B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.8B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $2.1B | $2.0B | ||
| Q2 24 | $2.1B | $2.0B | ||
| Q1 24 | $2.2B | $2.1B |
总资产GPORICUI
| Q4 25 | $3.0B | $4.1B | ||
| Q3 25 | $2.9B | $4.1B | ||
| Q2 25 | $3.0B | $4.1B | ||
| Q1 25 | $2.9B | $4.2B | ||
| Q4 24 | $2.9B | $4.2B | ||
| Q3 24 | $3.2B | $4.3B | ||
| Q2 24 | $3.2B | $4.3B | ||
| Q1 24 | $3.3B | $4.3B |
负债/权益比GPORICUI
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.39× | — | ||
| Q1 25 | 0.42× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.32× | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $185.4M | $60.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | — | 4.6% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $91.8M |
8季度趋势，按日历期对齐
经营现金流GPORICUI
| Q4 25 | $185.4M | $60.6M | ||
| Q3 25 | $209.1M | $56.7M | ||
| Q2 25 | $231.4M | $11.2M | ||
| Q1 25 | $177.3M | $51.3M | ||
| Q4 24 | $148.8M | $40.2M | ||
| Q3 24 | $189.7M | $36.1M | ||
| Q2 24 | $123.5M | $82.0M | ||
| Q1 24 | $188.0M | $45.8M |
自由现金流GPORICUI
| Q4 25 | — | $36.0M | ||
| Q3 25 | — | $27.6M | ||
| Q2 25 | — | $-8.5M | ||
| Q1 25 | — | $36.7M | ||
| Q4 24 | — | $16.1M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | — | $62.5M | ||
| Q1 24 | — | $29.9M |
自由现金流率GPORICUI
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | -1.5% | ||
| Q1 25 | — | 6.1% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 10.5% | ||
| Q1 24 | — | 5.3% |
资本支出强度GPORICUI
| Q4 25 | — | 4.6% | ||
| Q3 25 | — | 5.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | 2.8% |
现金转化率GPORICUI
| Q4 25 | 1.40× | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 1.25× | 0.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GPOR
| Natural Gas Production | $296.9M | 75% |
| Other | $42.7M | 11% |
| Naturalgasliquidsales | $35.2M | 9% |
| Oil And Condensate | $23.4M | 6% |
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
